Biohaven Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Biohaven Ltd. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue0.000.000.000.000.00
Cost of Revenue0.000.000.000.000.00
Gross Profit0.000.000.000.000.00
Operating Expenses
Research & Development795.87373.28437.07181.4998.46
Selling, General & Administrative89.2462.77130.8637.4116.05
Operating Expenses885.11436.05567.93218.90114.51
Operating Income-885.11-436.05-567.93-218.90-114.51
Other Income/Expense
Interest Income21.330.000.000.000.00
Interest Expense0.000.000.000.000.00
Other Income/Expense39.428.81-5.126.470.00
Income
Income Before Tax-845.69-409.55-569.84-212.43-118.67
Income Tax Expense0.74-1.380.441.370.00
Net Income-846.42-408.17-570.28-213.80-118.67
Net Income - Continuous Operations-846.42-408.17-570.28-213.800.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-877.26-429.14-566.55-217.51-114.43
EBIT-845.69-436.05-567.93-218.90-114.51
Depreciation & Amortization7.866.911.391.390.07
Earnings Per Share
Basic EPS-9.00-6.00-13.00-6.00-3.00
Diluted EPS-9.00-6.00-13.00-6.00-3.00
Basic Shares Outstanding91.2371.2044.7435.8239.38
Diluted Shares Outstanding91.2371.2044.7435.8239.38